Press releases
March 26, 2019
PledPharma will be presenting company’s drug development programs at today’s CMD in Stockholm
March 26, 2019
March 18, 2019
PledPharma’s drug candidate Aladote® granted Orphan Drug Designation
March 14, 2019
PledPharma Capital Markets Day, March 26
February 21, 2019
Year-end Report January-December 2018
February 11, 2019
Helene Depui Ekdal new Clinical Development Director
February 5, 2019
PledPharma Capital Markets Day
January 31, 2019
Aladote®’s data has been selected for presentation at The International Liver Congress
January 17, 2019
PledPharma presents PledOx®’s phase III program at the Gastrointestinal (GI) Cancers Symposium
December 24, 2018